Anti-anxiety drug as medical treatment for stuttering

Originally developed as an anti-anxiety drug, Pagoclone is becoming a more common treatment for stuttering. It blocks a chemical called dopamine in the brain. Research has suggested that people who stutter have an excess of dopamine in the area of the brain that controls speech timing.

It is estimated that over 3 million Americans stutter. Stuttering affects individuals of all ages but occurs most frequently in young children between the ages of 2 and 6 who are developing language.

Pagoclone’s effects are described as similar to alcohol but without the bad effects. It makes people feel relaxed and sociable, without feeling aggressive, nauseous, or uncoordinated. Pagoclone improved speech in 55 percent of the 130 patients who tested the drug with no major side effects and is still pending FDA’s approval.

Stuttering is a speech disorder in which the normal flow of speech is disrupted by frequent repetitions or prolongations of speech sounds, syllables or words and may be accompanied by rapid eye blinks, tremors of the lips or jaw, or other movements of the face or upper body that a person who stutters may use in an attempt to speak

Via http://www.news8austin.com/content/headlines/?ArID=190305&SecID=2

Incoming search terms:

• dr nasr bataineh
• MEDICATIONS FOR ANXIETY FROM STUTTERING
• anti anxiety medication for children who stutter
• stuttering l theanine
• pagoclone october 2011
• stuttering medicine 2011
• stuttering medicine in future
• stuttering medication 2011
• what antianxiety medication to people who stutter take?
• stuttering cure in future